203 related articles for article (PubMed ID: 23252868)
21. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT
Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852
[TBL] [Abstract][Full Text] [Related]
22. CD44 is of functional importance for colorectal cancer stem cells.
Du L; Wang H; He L; Zhang J; Ni B; Wang X; Jin H; Cahuzac N; Mehrpour M; Lu Y; Chen Q
Clin Cancer Res; 2008 Nov; 14(21):6751-60. PubMed ID: 18980968
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer.
Qiu ZX; Zhao S; Mo XM; Li WM
Int J Clin Exp Pathol; 2015; 8(6):6589-95. PubMed ID: 26261540
[TBL] [Abstract][Full Text] [Related]
24. Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer.
Neumann J; Löhrs L; Albertsmeier M; Reu S; Guba M; Werner J; Kirchner T; Angele M
Cancer Invest; 2015; 33(8):354-60. PubMed ID: 26068177
[TBL] [Abstract][Full Text] [Related]
25. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
[TBL] [Abstract][Full Text] [Related]
28. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
29. [Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cells].
Liu D; Li WM; Mo XM; Liu LX; Wang Y; Che GW; Wu Z; Gou JL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):827-31. PubMed ID: 19024325
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
Alamgeer M; Ganju V; Szczepny A; Russell PA; Prodanovic Z; Kumar B; Wainer Z; Brown T; Schneider-Kolsky M; Conron M; Wright G; Watkins DN
Thorax; 2013 Dec; 68(12):1095-104. PubMed ID: 23878161
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.
Mizukami T; Kamachi H; Mitsuhashi T; Tsuruga Y; Hatanaka Y; Kamiyama T; Matsuno Y; Taketomi A
BMC Cancer; 2014 Sep; 14():687. PubMed ID: 25240521
[TBL] [Abstract][Full Text] [Related]
33. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
35. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
36. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
37. The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
Miyata T; Oyama T; Yoshimatsu T; Higa H; Kawano D; Sekimura A; Yamashita N; So T; Gotoh A
Anticancer Res; 2017 May; 37(5):2541-2547. PubMed ID: 28476825
[TBL] [Abstract][Full Text] [Related]
38. Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma.
Brungs D; Lochhead A; Iyer A; Illemann M; Colligan P; Hirst NG; Splitt A; Liauw W; Vine KL; Pathmanandavel S; Carolan M; Becker TM; Aghmesheh M; Ranson M
Pathology; 2019 Aug; 51(5):474-480. PubMed ID: 31230819
[TBL] [Abstract][Full Text] [Related]
39. AC133 expression associated with poor prognosis in stage II colorectal cancer.
Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2.
Matsika A; Srinivasan B; Day C; Mader SA; Kiernan DM; Broomfield A; Fu J; Hooper JD; Kench JG; Samaratunga H
Pathology; 2015 Dec; 47(7):622-8. PubMed ID: 26517640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]